Compare Amphastar Pharmaceuticals Inc (AMPH) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs iShares Global Clean Energy ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while iShares Global Clean Energy ETF trades at $18.85. The key difference: iShares Global Clean Energy ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | ICLN | |
|---|---|---|
Market Cap | $826.08M | — |
Sector | Health | — |
52-Week High | $30.81 | $23.75 |
52-Week Low | $16.87 | $13.37 |
Enterprise Value | $1.22B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
ICLN trades at $19.25, down 0.41% with a bearish technical signal from moving averages. The ETF shows strong 2026 performance with clean energy sector momentum driven by AI demand and high oil prices. Recent news highlights policy risks from US permit delays affecting $121 billion in renewable investments, while China's 2030 EV targets provide long-term growth catalysts. The fund offers global diversification across 105 clean energy holdings.
Outlook remains cautiously optimistic despite near-term policy headwinds. The structural shift toward clean energy infrastructure and growing global investment support long-term growth potential. Key risks include regulatory uncertainty and competitive pressure from traditional energy ETFs offering higher yields. Current levels may present accumulation opportunities for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
